Kenbugul Jatta

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: ENDOCRINE PATHOLOGY. 2024;35(4):411-418
Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice
Hellgren LS; Stenman A; Jatta K; Condello V; Larsson C; Zedenius J; Juhlin CC
Article: TRANSLATIONAL LUNG CANCER RESEARCH. 2024;13(11):0
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study
Kamali C; Tsakonas G; Hydbring P; Jatta K; Berglund A; Viktorsson K; Lewensohn R; De Petris L; Ekman S
Article: ACTA ONCOLOGICA. 2023;62(12):1808-1814
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals
Skribek M; Brunnstrom H; Oskarsdottir G; Grive MP; Aricak O; Planck M; Jatta K; Naserhojati H; de Flon FH; Ekman S
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s353
P2.10-04 Real-World Outcome of Metastatic ALK-Positive Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
Kamali C; De Petris L; Jatta K; Viktorsson K; Lewensohn R; Ekman S; Hydbring P
Article: EUROPEAN THYROID JOURNAL. 2023;12(4):e230099
Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
Nilsson JN; Siikanen J; Condello V; Jatta K; Saini R; Hedman C; Lundgren CI; Juhlin CC
Article: CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. 2023;71(3):103401
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation
Xagoraris I; Stathopoulou K; Aulerio RD; He M; Ketscher A; Jatta K; de Flon FH; Barbany G; Rosenquist R; Westerberg LS; Rassidakis GZ
Article: DIAGNOSTIC CYTOPATHOLOGY. 2023;51(6):331-340
Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases
Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
Article: HEAD AND NECK PATHOLOGY. 2021;15(2):628-637
Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion
Juhlin CC; Asa SL; Jatta K; Rodsari HN; Shabo I; Haglund F; Delahunt B; Samaratunga H; Egevad L; Hoog A; Zedenius J
Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2021;23(2):212-222
Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential Advantages of the Digital Droplet PCR Technique
Hysek M; Jatta K; Hellgren LS; Stenman A; Larsson C; Zedenius J; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2020;31(1):77-83
Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson I-L; Branstrom R; Zedenius J; Juhlin CC
Article: DIAGNOSTIC PATHOLOGY. 2019;14(1):127
Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Hoog A; Juhlin CC
Article: CANCERS. 2019;11(10):E1443-1443
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
Hysek M; Paulsson JO; Jatta K; Shabo I; Stenman A; Hoog A; Larsson C; Zedenius J; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2019;30(3):246-248
TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up
Stenman A; Hysek M; Jatta K; Branstrom R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2019;511(2):260-265
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC
Lai Y; Kacal M; Kanony M; Stukan I; Jatta K; Kis L; Norberg E; Vakifahmetoglu-Norberg H; Lewensohn R; Hydbring P; Ekman S
Article: VIRCHOWS ARCHIV. 2018;473(5):639-643
TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine
Hysek M; Paulsson JO; Wang N; Jatta K; Lindh C; Fuentes-Martinez N; Shabo I; Zedenius J; Juhlin CC
Article: CIRCULATION JOURNAL. 2009;73(8):1531-1536
A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development - The Interleukin-1β:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis -
Olofsson PS; Sheikine Y; Jatta K; Ghaderi M; Samnegard A; Eriksson P; Sirsjoe A
Article: JOURNAL OF CLINICAL PATHOLOGY. 2009;62(1):70-76
Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease
Jatta K; Eliason G; Portela-Gomes GM; Grimelius L; Caro O; Nilholm L; Sirjsoe A; Piehl-Aulin K; Abdel-Halim SM
Article: ATHEROSCLEROSIS. 2006;189(2):458-463
Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls
Sheikine Y; Olsen B; Gharizadeh B; Jatta K; Tornvall P; Ghaderi M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2006;91(10):4107-4111
MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency
Ghaderi M; Gambelunghe G; Tortoioli C; Brozzetti A; Jatta K; Gharizadeh B; De Bellis A; Giraldi FP; Terzolo M; Betterle C; Falorni A
Article: JOURNAL OF VASCULAR RESEARCH. 2006;43(4):377-382
Expression of IL-1β, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells:: Effects of all-trans-retinoic acid
Wagsater D; Jatta K; Ocaya P; Dimberg J; Sirsjo A
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2005;25(7):e113-e116
The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents
Olofsson PS; Jatta K; Wågsäter D; Gredmark S; Hedin U; Paulsson-Berne G; Söderberg-Nauclér C; Hansson GK; Sirsjö A
Article: JOURNAL OF VASCULAR RESEARCH. 2005;42(3):266-271
Lipopolysaccharide-induced cytokine and chemokine expression in human carotid lesions
Jatta K; Wågsäter D; Norgren L; Stenberg B; Sirsjö A
Journal article: ATHEROSCLEROSIS PLUS. 2004;5(1):8
W01.34 Lipopolysaccharide-induced cytokine and chemokine expression in human carotid lesions
Jatta K; Norgren L; Stebberg B; Sirsjö A
Journal article: ATHEROSCLEROSIS PLUS. 2004;5(1):13
W01.56 Gene profiling of the atherosclerotic lesion after all-trans retinoic acid exposure
Ocaya P; Jatta K; Olofsson P; Stenberg B; Norgren L; Sirsjö A
Visa fler

Alla övriga publikationer

Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S353
Real-World Outcome of Metastatic ALK-Positive Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
Kamali C; De Petris L; Jatta K; Viktorsson K; Lewensohn R; Ekman S; Hydbring P
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1087
Real-world insights into non-small cell lung cancer patients with MET exon 14 skipping mutations: A Swedish retrospective study from two university hospitals
Skribek M; Brunnstrom H; Aricak O; Planck M; Jatta K; Oskarsdottir GN; Naserhojati H; Haglund F; Ekman S
Review: HEAD AND NECK PATHOLOGY. 2021;15(2):668-675
Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a SomaticDICER1Gene Mutation: Case Report and Review of the Literature
Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
Letter: ANNALS OF HEMATOLOGY. 2020;99(3):649-651
Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation
Rassidakis GZ; Stromberg O; Xagoraris I; Jatta K; Sonnevi K
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2013;8:S1202
THE CLINICAL IMPORTANCE OF EGFR-TESTING IN NON-SMALL CELL LUNG CANCER: THREE YEAR EXPERIENCE FROM KAROLINSKA UNIVERSITY HOSPITAL IN SWEDEN
Mindus S; Jatta K; Elmberger G; Kolbeck K
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2013;8:S906-S907
ALK-EML4-TESTING IN NON-SMALL CELL LUNG CANCER: EXPERIENCES FROM KAROLINSKA UNIVERSITY HOSPITAL IN SWEDEN
Mindus S; Jatta K; Elmberger G; De Petris L; Kolbeck K
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):214
Polymorphism in the CYP26B1 gene and association with the susceptibility of myocardial infarction
Krivospitskaya O; Jatta K; Johansson L; Jansson JH; Hurtig-Wennlof A; Olofsson P; Sirsjo A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):280
Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls
Sheikine Y; Olsen B; Gharizadeh B; Jatta K; Tornvall P; Ghaderi M
Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S127-S128
Influence of eotaxin 67g>a polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls.
Sheikine Y; Olsen B; Gharizadeh B; Jatta K; Tornvall P; Ghaderi M
Conference publication: ATHEROSCLEROSIS SUPPLEMENTS. 2004;5(1):13
Gene profiling of the atherosclerotic lesion after all-trans retinoic acid exposure
Ocaya P; Jatta K; Olofsson P; Stenberg B; Norgren L; Sirsjö A

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI